266 related articles for article (PubMed ID: 22326768)
1. Pathway-based identification of a smoking associated 6-gene signature predictive of lung cancer risk and survival.
Guo NL; Wan YW
Artif Intell Med; 2012 Jun; 55(2):97-105. PubMed ID: 22326768
[TBL] [Abstract][Full Text] [Related]
2. Network-Based Identification of Smoking-Associated Gene Signature for Lung Cancer.
Wan YW; Xiao C; Guo NL
Proceedings (IEEE Int Conf Bioinformatics Biomed); 2010 Dec; 2010():479-484. PubMed ID: 25984394
[TBL] [Abstract][Full Text] [Related]
3. Signaling pathway-based identification of extensive prognostic gene signatures for lung adenocarcinoma.
Wan YW; Beer DG; Guo NL
Lung Cancer; 2012 Apr; 76(1):98-105. PubMed ID: 22047960
[TBL] [Abstract][Full Text] [Related]
4. Hybrid models identified a 12-gene signature for lung cancer prognosis and chemoresponse prediction.
Wan YW; Sabbagh E; Raese R; Qian Y; Luo D; Denvir J; Vallyathan V; Castranova V; Guo NL
PLoS One; 2010 Aug; 5(8):e12222. PubMed ID: 20808922
[TBL] [Abstract][Full Text] [Related]
5. Network-based differential gene expression analysis suggests cell cycle related genes regulated by E2F1 underlie the molecular difference between smoker and non-smoker lung adenocarcinoma.
Wu C; Zhu J; Zhang X
BMC Bioinformatics; 2013 Dec; 14():365. PubMed ID: 24341432
[TBL] [Abstract][Full Text] [Related]
6. A novel network model identified a 13-gene lung cancer prognostic signature.
Guo NL; Wan YW; Bose S; Denvir J; Kashon ML; Andrew ME
Int J Comput Biol Drug Des; 2011; 4(1):19-39. PubMed ID: 21330692
[TBL] [Abstract][Full Text] [Related]
7. A 12-gene genomic instability signature predicts clinical outcomes in multiple cancer types.
Mettu RK; Wan YW; Habermann JK; Ried T; Guo NL
Int J Biol Markers; 2010; 25(4):219-28. PubMed ID: 21161944
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
[No Abstract] [Full Text] [Related]
9. Relation between smoking history and gene expression profiles in lung adenocarcinomas.
Staaf J; Jönsson G; Jönsson M; Karlsson A; Isaksson S; Salomonsson A; Pettersson HM; Soller M; Ewers SB; Johansson L; Jönsson P; Planck M
BMC Med Genomics; 2012 Jun; 5():22. PubMed ID: 22676229
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
11. A seven-long noncoding RNA signature predicts relapse in patients with early-stage lung adenocarcinoma.
Zhou H; Zhang H; Chen J; Cao J; Liu L; Guo C; Huang G; Zeng D
J Cell Biochem; 2019 Sep; 120(9):15730-15739. PubMed ID: 31050375
[TBL] [Abstract][Full Text] [Related]
12. An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers.
Dama E; Melocchi V; Dezi F; Pirroni S; Carletti RM; Brambilla D; Bertalot G; Casiraghi M; Maisonneuve P; Barberis M; Viale G; Vecchi M; Spaggiari L; Bianchi F; Di Fiore PP
Clin Cancer Res; 2017 Jan; 23(1):62-72. PubMed ID: 27358486
[TBL] [Abstract][Full Text] [Related]
13. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
Shukla S; Evans JR; Malik R; Feng FY; Dhanasekaran SM; Cao X; Chen G; Beer DG; Jiang H; Chinnaiyan AM
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27707839
[TBL] [Abstract][Full Text] [Related]
14. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
[TBL] [Abstract][Full Text] [Related]
15. Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.
Peng F; Wang R; Zhang Y; Zhao Z; Zhou W; Chang Z; Liang H; Zhao W; Qi L; Guo Z; Gu Y
Mol Cancer; 2017 Jun; 16(1):98. PubMed ID: 28587642
[TBL] [Abstract][Full Text] [Related]
16. Network-based approach identified cell cycle genes as predictor of overall survival in lung adenocarcinoma patients.
Li Y; Tang H; Sun Z; Bungum AO; Edell ES; Lingle WL; Stoddard SM; Zhang M; Jen J; Yang P; Wang L
Lung Cancer; 2013 Apr; 80(1):91-8. PubMed ID: 23357462
[TBL] [Abstract][Full Text] [Related]
17. Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma.
Guo L; Ma Y; Ward R; Castranova V; Shi X; Qian Y
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3344-54. PubMed ID: 16740756
[TBL] [Abstract][Full Text] [Related]
18. Confirmation of gene expression-based prediction of survival in non-small cell lung cancer.
Guo NL; Wan YW; Tosun K; Lin H; Msiska Z; Flynn DC; Remick SC; Vallyathan V; Dowlati A; Shi X; Castranova V; Beer DG; Qian Y
Clin Cancer Res; 2008 Dec; 14(24):8213-20. PubMed ID: 19088038
[TBL] [Abstract][Full Text] [Related]
19. Predicting the Clinical Outcome of Lung Adenocarcinoma Using a Novel Gene Pair Signature Related to RNA-Binding Protein.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li J; Xiao Y
Biomed Res Int; 2020; 2020():8896511. PubMed ID: 33195699
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
